Black men with clinical prostatitis may have lower risk of prostate cancer

Black men with clinical prostatitis may have lower risk of prostate cancer

According to the American Cancer Society, prostate cancer is the second leading cause of cancer death in men in the United States, behind lung cancer. It is also the most common type of cancer in men other than skin cancer. And according to the Prostate Cancer Foundation, African-American men are nearly 1.6 times more likely to be diagnosed with prostate cancer than Caucasian men and 2.4 times more likely to die from the disease.

 

Read More

Top healthy food for Prostate

Top healthy food for Prostate

Cranberries, strawberries, blackberries, raspberries. Cranberries also helps bladder health by preventing bacteria from attaching to urinary tract walls. High in vitamin C and antioxidants. Vitamin C may help ease BPH symptoms by promoting urination and reducing swelling. Antioxidants prevent damage from free radicals – molecules that attack healthy cells and can contribute to cancer risk

Read More

Prostate cancer deaths linked to stress

Research suggests that having high levels of stress may increase a man’s risk of prostate cancer death. This includes men with advanced prostate cancer and localized prostate cancer.

Read More

With fewer PSA screenings, will more men die of prostate cancer?

There has been controversy over PSA screening for a number of years. The evidence began piling up about a decade ago that the PSA test leads to overdiagnosis and overtreatment. It is true that an elevated PSA may indicate prostate cancer. However, the PSA is not specific for prostate cancer and could also indicate other prostate related conditions. Many argue that prostate cancers are so slow growing that they may never even put a man’s health or life at risk, and that many men with prostate cancer will die with it, not of it.

Read More

Fewer Men are being screened for Prostate Cancer

Two new studies published on Tuesday in The Journal of the American Medical Association highlight that likely in accordance to USPSTF recommendations against screening, fewer men are being screened for prostate cancer and fewer cases of early state prostate cancer are being detected. The question is, if decreased screening is leading to a lower rate of diagnosis, what does this mean for the future of prostate cancer patients? 

Read More